{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:09:44Z","timestamp":1762254584069,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["H2019063"],"award-info":[{"award-number":["H2019063"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013088","name":"Qinglan Project of Jiangsu Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018592","name":"\u201c333 Project\u201d of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Science and Technology Project of Suzhou Vocational Health College","award":["SZWZY202114"],"award-info":[{"award-number":["SZWZY202114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00251-023-01307-7","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T10:04:36Z","timestamp":1688551476000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dysregulated PD-L2 is correlated with disease activity and inflammation in rheumatoid arthritis"],"prefix":"10.1007","volume":"75","author":[{"given":"Jian","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yachun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yundi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-6835","authenticated-orcid":false,"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"1307_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"1307_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/febs.13576","volume":"283","author":"S Bittner","year":"2016","unstructured":"Bittner S, Knoll G, Fullsack S, Kurz M, Wajant H, Ehrenschwender M (2016) Soluble TL1A is sufficient for activation of death receptor 3. FEBS J 283:323\u2013336","journal-title":"FEBS J"},{"key":"1307_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"MF Bustamante","year":"2017","unstructured":"Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M (2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:110","journal-title":"Arthritis Res Ther"},{"key":"1307_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100028","volume":"3","author":"SR Greisen","year":"2020","unstructured":"Greisen SR, Kragstrup TW, Thomsen JS, Hansen AS, Krishnamurthy A, Horslev-Petersen K, Hetland ML, Stengaard-Pedersen K, Ostergaard M, Ornbjerg LM et al (2020) Programmed death ligand 2 - a link between inflammation and bone loss in rheumatoid arthritis. J Transl Autoimmun 3:100028","journal-title":"J Transl Autoimmun"},{"key":"1307_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192704","volume":"13","author":"Y Guo","year":"2018","unstructured":"Guo Y, Walsh AM, Canavan M, Wechalekar MD, Cole S, Yin X, Scott B, Loza M, Orr C, McGarry T et al (2018) Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS ONE 13:e0192704","journal-title":"PLoS ONE"},{"key":"1307_CR6","first-page":"1410","volume":"30","author":"S Hatachi","year":"2003","unstructured":"Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, Saura R, Kurosaka M, Honjo T, Kumagai S (2003) CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol 30:1410\u20131419","journal-title":"J Rheumatol"},{"key":"1307_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4049\/jimmunol.1901008","volume":"205","author":"K Inaba","year":"2020","unstructured":"Inaba K, Yashiro T, Hiroki I, Watanabe R, Kasakura K, Nishiyama C (2020) Dual roles of PU.1 in the expression of PD-L2: direct transactivation with IRF4 and indirect epigenetic regulation. J Immunol 205:822\u2013829","journal-title":"J Immunol"},{"key":"1307_CR8","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.4049\/jimmunol.171.8.4156","volume":"171","author":"T Kanai","year":"2003","unstructured":"Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K et al (2003) Blockade of B7\u2013H1 suppresses the development of chronic intestinal inflammation. J Immunol 171:4156\u20134163","journal-title":"J Immunol"},{"key":"1307_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.14712\/fb2020066040117","volume":"66","author":"J Karolova","year":"2020","unstructured":"Karolova J, Radek M, Helman K, Spacek M, Trneny M, Klener P (2020) PD-1, PD-L1 and PD-L2 expression in mantle cell lymphoma and healthy population. Folia Biol (Praha) 66:117\u2013122","journal-title":"Folia Biol (praha)"},{"key":"1307_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677\u2013704","journal-title":"Annu Rev Immunol"},{"key":"1307_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587460","volume":"11","author":"M Khan","year":"2020","unstructured":"Khan M, Zhao Z, Arooj S, Fu Y, Liao G (2020) Soluble PD-1: predictive, prognostic, and therapeutic value for cancer immunotherapy. Front Immunol 11:587460","journal-title":"Front Immunol"},{"key":"1307_CR12","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1073\/pnas.0804453105","volume":"105","author":"E Lazar-Molnar","year":"2008","unstructured":"Lazar-Molnar E, Yan Q, Cao E, Ramagopal U, Nathenson SG, Almo SC (2008) Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2. Proc Natl Acad Sci U S A 105:10483\u201310488","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1307_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13075-017-1276-2","volume":"19","author":"W Meng","year":"2017","unstructured":"Meng W, Zhu Z, Jiang X, Too CL, Uebe S, Jagodic M, Kockum I, Murad S, Ferrucci L, Alfredsson L et al (2017) DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis. Arthritis Res Ther 19:71","journal-title":"Arthritis Res Ther"},{"key":"1307_CR14","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.molimm.2011.06.436","volume":"48","author":"N Messal","year":"2011","unstructured":"Messal N, Serriari NE, Pastor S, Nunes JA, Olive D (2011) PD-L2 is expressed on activated human T cells and regulates their function. Mol Immunol 48:2214\u20132219","journal-title":"Mol Immunol"},{"key":"1307_CR15","doi-asserted-by":"crossref","unstructured":"Pawlowska A, Kwiatkowska A, Suszczyk D, Chudzik A, Tarkowski R, Barczynski B, Kotarski J, Wertel I (2021) Clinical and prognostic value of antigen-presenting cells with PD-L1\/PD-L2 expression in ovarian cancer patients. Int J Mol Sci 22","DOI":"10.3390\/ijms222111563"},{"key":"1307_CR16","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001","journal-title":"Nat Rev Dis Primers"},{"key":"1307_CR17","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"key":"1307_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN (2018) Regulation and Function of the PD-L1 Checkpoint. Immunity 48:434\u2013452","journal-title":"Immunity"},{"key":"1307_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.imlet.2020.09.001","volume":"227","author":"M Tong","year":"2020","unstructured":"Tong M, Fang X, Yang J, Wu P, Guo Y, Sun J (2020) Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity. Immunol Lett 227:96\u2013101","journal-title":"Immunol Lett"},{"key":"1307_CR20","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.4049\/jimmunol.169.10.5538","volume":"169","author":"T Yamazaki","year":"2002","unstructured":"Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K et al (2002) Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169:5538\u20135545","journal-title":"J Immunol"},{"key":"1307_CR21","doi-asserted-by":"publisher","first-page":"10377","DOI":"10.1038\/s41598-020-67497-2","volume":"10","author":"H Yasuoka","year":"2020","unstructured":"Yasuoka H, Asai A, Ohama H, Tsuchimoto Y, Fukunishi S, Higuchi K (2020) Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis. Sci Rep 10:10377","journal-title":"Sci Rep"},{"key":"1307_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2567.2007.02723.x","volume":"123","author":"G Zhang","year":"2008","unstructured":"Zhang G, Hou J, Shi J, Yu G, Lu B, Zhang X (2008) Soluble CD276 (B7\u2013H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology 123:538\u2013546","journal-title":"Immunology"},{"key":"1307_CR23","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/eji.200737461","volume":"37","author":"X Zhong","year":"2007","unstructured":"Zhong X, Tumang JR, Gao W, Bai C, Rothstein TL (2007) PD-L2 expression extends beyond dendritic cells\/macrophages to B1 cells enriched for V(H)11\/V(H)12 and phosphatidylcholine binding. Eur J Immunol 37:2405\u20132410","journal-title":"Eur J Immunol"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-023-01307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00251-023-01307-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-023-01307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T11:02:03Z","timestamp":1695294123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00251-023-01307-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1007\/s00251-023-01307-7","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"type":"print","value":"0093-7711"},{"type":"electronic","value":"1432-1211"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Suzhou Vocational Health College (approval No. SZHCTEC-2020-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}